Skip to main content
. Author manuscript; available in PMC: 2008 May 12.
Published in final edited form as: Lancet. 2007 Oct 6;370(9594):1230–1239. doi: 10.1016/S0140-6736(07)61539-6

Table 6.

Proportion of children with multiple episodes per year by treatment group

Placebo (n=2032) Zinc (n=2038) RR (95% CI)
Diarrhoea
>1 953 (47%) 997 (49%) 1·03 (0·94−1·14)
>2 661 (33%) 641 (31%) 0·97 (0·85−1·10)
>3 422 (21%) 397 (19%) 0·93 (0·79−1·10)
>4 269 (13%) 269 (13%) 0·98 (0·80−1·20)
Persistent diarrhoea
>1 8 (<1%) 7 (<1%) 0·87 (0·32−2·36)
Dysentery
>1 73 (4%) 88 (4%) 1·27 (0·85−1·89)
>2 20 (1%) 27 (1%) 1·33 (0·70−2·51)
ALRI
>1 459 (23%) 480 (24%) 1·04 (0·89−1·22)
>2 226 (11%) 257 (13%) 1·14 (0·91−1·43)
>3 102 (5%) 131 (6%) 1·26 (0·91−1·74)

Data are n (%). RR=relative risk. ALRI=acute lower respiratory illness.